Medical Journals

Action of Imipramine on Activated Atp-sensitive K(+) Channels in Interstitial Cells of Cajal from Murine Small Intestine.

Authors:
  • Choi Seok
  • Park Chan Guk
  • Kim Man Yoo
  • Lim Geon Han
  • Kim Jin Ho
  • Yeum Cheol Ho
  • Yoon Pyung Jin
  • So Insuk
  • Kim Ki Whan
  • Jun Jae Yeoul

From: Department of Physiology, College of Medicine, Chosun University, 375 Seosuk-dong, Gwangju, Korea.

Life sciences

  • Publish Date: Apr 2006
  • ISSN: 0024-3205
  • Volume: 78
  • Issue: 20
  • Pages: 2322-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Choi Seok, Park Chan Guk, Kim Man Yoo, et al. Action of Imipramine on Activated Atp-sensitive K(+) Channels in Interstitial Cells of Cajal from Murine Small Intestine.. Life Sci. Apr 2006;78:2322-8

Abstract

Tricyclic antidepressants have been widely used for the treatment of depression and as a therapeutic agent for the altered gastrointestinal (GI) motility of irritable bowel syndrome (IBS). The aim of this study was to clarify whether antidepressants directly modulate pacemaker currents in cultured interstitial cells of Cajal (ICC). We used the whole-cell patch-clamp techniques at 30 degrees C in cultured ICC from the mouse small intestine. Treatment of pinacidil, an ATP-sensitive K(+) channel opener, in the ICC using the current clamping mode, produced hyperpolarization of the membrane potential and decreased the amplitude of the pacemaker potentials. With the voltage clamp mode, we observed a decrease in the frequency and amplitude of pacemaker currents and increases in the resting outward currents. These effects of pinacidil on pacemaker potentials and currents were completely suppressed by glibenclamide, an ATP-sensitive K(+) channel blocker. Also, with the current clamp mode, imipramine blocked the affect of pinacidil on the pacemaker potentials. Observations of the voltage clamp mode with imipramine, desipramine and amitryptyline suppressed the action of pinacidil in the ICC. Next, we examined whether protein kinase C (PKC) and the G protein are involved in the action of imipramine on pinacidil induced pacemaker current inhibition. We used chelerythrine, a potent PKC inhibitor and GDPbetaS, a nonhydrolyzable guanosine 5-diphosphate (GDP) analogue that permanently inactivates GTP-binding proteins. We found that pretreatment with chelerythrine and intracellular application of GDPbetaS had no influence on the blocking action of imipramine on inhibited pacemaker currents by pinacidil. We conclude that imipramine inhibited the activated ATP-sensitive K(+) channels in ICC. This action does not appear to be mediated through the G protein and protein kinase C. Furthermore, this study may suggest another possible mechanism for tricyclic antidepressants related modulation of GI motility.

Mesh Headings (Keywords): ATP-Binding Cassette Transporters, Animals, Antidepressive Agents, Tricyclic, Cells, Cultured, Enzyme Inhibitors, Female, GTP-Binding Proteins, Gastrointestinal Motility, Imipramine, Intestine, Small, Male, Mice, Mice, Inbred BALB C, Patch-Clamp Techniques, Pinacidil, Potassium Channels, Inwardly Rectifying, Protein Kinase C, Vasodilator Agents


Check for Full Text / PubMed Unique Identifier (PMID): 16266721


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.